Search Results

1 - 10 of 674 items :

  • "metabolic syndrome" x
Clear All
Abnormal lipid metabolism in metabolic syndrome: an epigenetic perspective

References 1. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes. 2011;60:1329-39. DOI: 10.2337/db10-1011. 2. Bruce KD, Hanson MA. The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr. 2010;140(3):648-52. DOI: 10.3945/ jn.109.111179. 3. Laker RC, Wlodek ME, Connelly JJ, Yan Z. Epigenetic origins of metabolic disease: The impact of the maternal condition to the offspring

Open access
Low Total Testosterone-Component of Metabolic Syndrome

? Transl Androl Urol 5(6):898-908,2016 5. Lopez DS, Advani S, Tsilidis KK, Wang R, Canfield S. Endogenous and exogenous testosterone and prostate cancer: decreased, increased or null-risk? Transl Androl Urol . 6(3): 566-579, 2017 6. Bjorntorp P . Endocrine abnormalities in obesity. Diabetes Rev 5: 52-68, 1997 7. Laaksonen DE, Niskanen L, Punnonen K et al . Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27(5):1036-1041, 2004 8. Kolovou GD, Anagnostopoulou KK, Salpea

Open access
Metabolic Syndrome in Rheumatoid Arthritis

References 1. Breitrose, PE. History (of the Stanford Prevention Research Center). [Online] Stanford Prevention Research Center. [Dátum: 1. FEB 2011.] http://prevention.stanford.edu/about/history.html. 2. Chung, CP; Avalos, I; Oeser, A; Gebretsadik, T; Shintani, A; Raggi, P; Michael Stein, C. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis. 2007, 66, 208-214 pp. 3. Chung, CP

Open access
The Role of Distubances of Phosphate Metabolism in Metabolic Syndrome

References 1. Olufadi R, Byrne CD . Clinical and laboratory diagnosis of the metabolic syndrome. J Clin Pathol 61: 697-706, 2008. 2. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005. 3. Hanley AJ, Karter AJ, Williams K et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin

Open access
The Relation Between Metabolic Syndrome and Testosterone Level

R eferences 1. FontbonneA, Charles MA, Thibult N et al. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow up. Diabetologia 34: 356-361, 1991. 2. Einhorn D, Reaven GM, Cobin RH et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9: 237-252, 2003 3. International Diabetic Federation . The IDF consensus worldwide definition of the metabolic syndrome. The metabolic syndrome. IDF Communications pp 1

Open access
Prevalence of Metabolic Syndrome and of Cardiovascular Risk Factors

References 1. Heinsch R. Avizul Comitetului Economic și Social European privind consecin ele îmbătrânirii popula iei asupra sistemelor de sănătate și de protec ie socială (aviz exploratoriu). Jurnalul Oficial al Uniunii Europene. 2011/C 44/02, p 10-16. 2. Diabetes Canada Clinical Practice Guidelines Expert Committee, Punthakee Z, Goldenberg R, Katz P. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Can J Diabetes. 2018;42 Suppl 1:S10-S15. 3. O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at

Open access
Levels Of Resistin And Visfatin In Patients With Metabolic Syndrome

References 1. Galik S, Oakhill J, Steinberg G. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129-39. 2. Karastegiou K, Mohamed-Ali V. The autocrine and paracrine roles of adipokines. Mol Cell Endocrinol. 2010;318(1-2):69-78. 3. Koleva D, Orbetzova M, Atanasova P. Adipose tissue hormones and appetite and body weight regulators in insulin resistance. Folia Med. 2013;55(11):25-32. 4. Deng Y, Scherer P. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci. 2010;1212:E1-E19. doi: 10

Open access
Perspectives on the Nutritional Management of Metabolic Syndrome in Asia: People, Practice and Programmes

R eferences 1. Grundy SM. Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr 83: 1248-1251, 2006. 2. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289-2304, 2005. 3. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung and Blood Institute

Open access
Prevalence of Metabolic Syndrome in Psoriatic Arthritis and Rheumatoid Arthritis

;72:211-216. 4. Ramonda R, Lo Nigro A, Modesti V, et al. Atherosclerosis in psoriatic arthritis. Autoimmun Rev. 2011;10:773-778. 5. Kimhi O, Caspi D, Bornstein NM, et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum. 2007;36:203-209. 6. Vitale C, Marazzi G, Volterrani M, et al. Metabolic syndrome. Minerva Med. 2006;97:219-229. 7. Raychaudhuri SK, Chatterjee S, Nguyen C, et al. Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis

Open access
Metabolic Syndrome and Nonalcoholic Fatty Liver Disease

Bibliography 1. Yki-Jarvinen. H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. LancetDiabetes Endocrinol 2014; 2(11): 901–10 2. Lonardo A, Ballestri S, Marchesini G et al. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Dig LiverDis 2015; 47: 181–90. 3. Fukuda T, Hamaguchi M, Kojima T et al. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. Liver Int 2016; 36: 275–83. 4. Matteoni C, Younossi Z, Gramlich T et al

Open access